Blood Product Requirement in Childhood Acute Lymphoblastic Leukemia in Relation to Chemotherapy Regimens

Creative Commons License

Gudeloglu E., Albayrak D.

IRANIAN JOURNAL OF PEDIATRICS, vol.30, no.3, 2020 (SCI-Expanded, Scopus) identifier identifier

  • Publication Type: Article / Article
  • Volume: 30 Issue: 3
  • Publication Date: 2020
  • Doi Number: 10.5812/ijp.100823
  • Journal Name: IRANIAN JOURNAL OF PEDIATRICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, CINAHL, EMBASE, Veterinary Science Database
  • Keywords: Acute Lymphoblastic Leukemia, Blood Transfusions, Chemotherapy, Child, CELL TRANSFUSION, CHILDREN, SURVIVAL
  • Open Archive Collection: AVESIS Open Access Collection
  • Ondokuz Mayıs University Affiliated: Yes

Abstract

Background: Along with lack of studies that systematically address the transfusion requirements and triggers in acute leukemia, no study to date has addressed the blood product use with respect to ongoing chemotherapy (CT) in pediatric acute lymphoblastic leukemia (ALL) patients.